Feasibility study of the treatment of primary unresectable carcinoma of the pancreas with 103Pd brachytherapy

scientific article published on May 1996

Feasibility study of the treatment of primary unresectable carcinoma of the pancreas with 103Pd brachytherapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0360-3016(95)02136-1
P698PubMed publication ID8635943

P2093author name stringBrennan MF
Casper ES
Harrison LB
Anderson L
Mychalczak B
Raben A
Minsky B
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectpancreasQ9618
brachytherapyQ896687
P304page(s)351-356
P577publication date1996-05-01
P1433published inInternational Journal of Radiation Oncology Biology PhysicsQ2296252
P1476titleFeasibility study of the treatment of primary unresectable carcinoma of the pancreas with 103Pd brachytherapy
P478volume35

Reverse relations

cites work (P2860)
Q33783647AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association
Q37277969Borderline resectable pancreatic cancer: on the edge of survival
Q35583949Chemoradiation in pancreatic adenocarcinoma: a literature review
Q37856903Intraluminal radioactive stent compared with covered stent alone for the treatment of malignant esophageal stricture
Q39431373Local control of experimental malignant pancreatic tumors by treatment with a combination of chemotherapy and intratumoral 224radium-loaded wires releasing alpha-emitting atoms
Q37426341Perioperative high dose rate (HDR) brachytherapy in unresectable locally advanced pancreatic tumors
Q44286067Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head
Q37123115Stereotactic body radiation therapy: transcending the conventional to improve outcomes
Q74387901[3D-Ct-planned interstitial HDR brachytherapy + percutaneous irradiation and chemotherapy in inoperable pancreatic carcinoma. Methods and clinical outcome]

Search more.